Back to top

Rafael Holdings Advances Phase 3 Study for NPC1 Treatment

Rafael Holdings ( ($RFL) ) just unveiled an announcement. On June 18, 2025, Rafael Holdings announced the continuation of its 96-week pivotal phase...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: